Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biophytis Sa ADR (BPTS)

Biophytis Sa ADR (BPTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,887
  • Shares Outstanding, K 351
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,430 K
  • EBIT $ 0 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/16/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.05 +2.11%
on 04/25/24
18.80 -56.28%
on 04/09/24
-6.81 (-45.32%)
since 03/25/24
3-Month
8.05 +2.11%
on 04/25/24
24.00 -65.75%
on 02/28/24
-11.38 (-58.06%)
since 01/25/24
52-Week
8.05 +2.11%
on 04/25/24
168.80 -95.13%
on 05/01/23
-127.38 (-93.94%)
since 04/25/23

Most Recent Stories

More News
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 58.23 (+0.60%)
ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.37 (-2.14%)
ONCY : 0.9800 (-1.85%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
BMY : 58.23 (+0.60%)
Russell 2000 ETF Momentum Sparks Volatility In Small Caps

The iShares Russell 2000 ETF (NYSE: IWM) impressive upward momentum has led to a volume, attention, and volatility surge in the small-cap market.

IWM : 234.44 (+1.52%)
BPTS : 8.22 (-15.28%)
GP : 0.8182 (+4.23%)
PWM : 1.0300 (+0.98%)
Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 30, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics...

BPTS : 8.22 (-15.28%)
Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress

PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company...

BPTS : 8.22 (-15.28%)
Biophytis: Results of the Combined General Meeting on June 21, 2022

All ordinary and extraordinary resolutions presented by the company have been adopted

BPTS : 8.22 (-15.28%)
Biophytis: Convening of Another Combined General Meeting at a Later Date

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 3, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on...

BPTS : 8.22 (-15.28%)
Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 12, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on...

BPTS : 8.22 (-15.28%)
Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 19, 2022 / Biophytis SA ((NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused...

BPTS : 8.22 (-15.28%)
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives

- Success of Nasdaq IPO in February 2021 - €23.9M of available cash on December 31 2021 and new financing instruments for a total of €42M allowing financial visibility beyond mid 2023 - Strong growth...

BPTS : 8.22 (-15.28%)

Business Summary

Biophytis SA is a clinical-stage biotechnology company. It specialized in the development of therapeutics which slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering...

See More

Key Turning Points

3rd Resistance Point 9.68
2nd Resistance Point 9.32
1st Resistance Point 8.77
Last Price 8.22
1st Support Level 7.86
2nd Support Level 7.50
3rd Support Level 6.95

See More

52-Week High 168.80
Fibonacci 61.8% 107.39
Fibonacci 50% 88.42
Fibonacci 38.2% 69.46
Last Price 8.22
52-Week Low 8.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar